Krisstina Gowin, DO

-
Assistant Professor, Medicine
Biography
Krisstina Gowin, DO is an Assistant Professor of Medicine at the University of Arizona. Dr. Gowin graduated from Chicago College of Osteopathic Medicine in 2009, where she received a merit scholarship and recognition from the American Women’s Medical Association for outstanding academic achievement. She completed internal medicine residency at University of Southern California, hematology and medical oncology training at Mayo Clinic in Arizona, fellowship training in integrative medicine at the University of Arizona. She is board certified in medical oncology, internal medicine and hematology.
Cancer Focus
Dr. Krisstina Gowin’s clinical interests focus on myeloproliferative neoplasms, plasma cell dyscrasias, multiple myeloma and integrative oncology. She is also a member of the hematopoietic cellular therapy and transplant team. Dr. Gowin is passionate about integrative medicine and is committed to supporting patients through their journey.
Selected Publications
Gowin, K., B. T. Langlais, H. E. Kosiorek, A. Dueck, D. Millstine, J. Huberty, R. Eckert, and R. A. Mesa, "The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.", Cancer Med, vol. 9, issue 24, pp. 9445-9453, 2020 12. PMCID: PMC7774715 PMID: 33140580
Gowin, K., K. Ballen, K. Woo Ahn, Z-H. Hu, H. Ali, M. O. Arcasoy, R. Devlin, M. Coakley, A. T. Gerds, M. Green, et al., "Survival following allogeneic transplant in patients with myelofibrosis.", Blood Adv, vol. 4, issue 9, pp. 1965-1973, 2020 05 12. PMCID: PMC7218417 PMID: 32384540
Mann, S., M. Sidhu, and K. Gowin, "Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy.", Nutrients, vol. 12, issue 8, 2020 Jul 26. PMCID: PMC7468768 PMID: 32722632
Ma, V. T., P. S. Boonstra, K. Menghrajani, C. Perkins, K. L. Gowin, R. A. Mesa, J. R. Gotlib, and M. Talpaz, "Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics.", Clin Lymphoma Myeloma Leuk, vol. 18, issue 5, pp. e201-e210, 2018 05. PMCID: PMC5927833 PMID: 29574002
Huberty, J., R. Eckert, L. Larkey, K. Gowin, J. Mitchell, and R. Mesa, "Perceptions of Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention: A Qualitative Study.", Integr Cancer Ther, vol. 17, issue 4, pp. 1150-1162, 2018 12. PMCID: PMC6247535 PMID: 30352518
Menghrajani, K., P. S. Boonstra, J. A. Mercer, C. Perkins, K. L. Gowin, A. A. Weber, R. Mesa, J. R. Gotlib, L. Wang, J. W. Singer, et al., "Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis.", Leuk Lymphoma, pp. 1-7, 2018 Sep 20. PMID: 30234400
Huberty, J., R. Eckert, K. Gowin, J. Mitchell, A. C. Dueck, B. F. Ginos, L. Larkey, and R. Mesa, "Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms.", Haematologica, vol. 102, issue 10, pp. e384-e388, 2017 10. PMCID: PMC5622867 PMID: 28596279
Eckert, R., J. Huberty, K. Gowin, R. Mesa, and L. Marks, "Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research.", Integr Cancer Ther, vol. 16, issue 4, pp. 439-450, 2017 12. PMCID: PMC5739136 PMID: 27458250
Gowin, K., H. Kosiorek, A. Dueck, J. Mascarenhas, R. Hoffman, C. Reeder, J. Camoriano, R. Tibes, K. Gano, J. Palmer, et al., "Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.", Leuk Res, vol. 60, pp. 31-35, 2017 09. PMID: 28646676